Connie Batlevi, MD, PhD, explains the treatment options for relapsed/refractory follicular lymphoma and discusses a recent drug approval.
EP. 1: Current Treatment Options and Considerations for Relapsed/Refractory Follicular Lymphoma
Connie Batlevi, MD, PhD, discusses the rate of patient relapse and current treatment options and considerations for relapsed/refractory follicular lymphoma.
EP. 2: Third Line Therapies in R/R FL
An expert in follicular lymphoma highlights the therapies available for third-line relapsed/refractory treatment options.
EP. 3: Use of Tazemetostat in R/R FL
Connie Batlevi, MD, PhD, explains the recent approval of tazemetostat, as well as the use of molecular testing in follicular lymphoma.
EP. 4: Sequencing Changes in R/R FL Therapies
Connie Batlevi, MD, PhD, discusses how the sequencing of follicular lymphoma therapies has changed in the past year and looks to the future with the upcoming American Society of Hematology (ASH) annual meeting.
EP. 5: OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates
Connie Batlevi, MD, PhD, detailed important updates in therapies for relapsed/refractory follicular lymphoma in this episode of CancerNetwork’s® podcast.
EP. 6: Updates in Therapies of Relapsed and Refractory Follicular Lymphoma
In this CancerNetwork® OncView™ program, faculty panelist Connie Batlevi, MD, PhD, explains the treatment options in this disease space and discusses a recent drug approval.
2 Clarke Drive Cranbury, NJ 08512